Blood Typing and Transfusion Compatibility

Also written as ABO typing, Rh typing, Blood group determination.

Blood typing determines ABO and Rh status to guide safe transfusion and prevent hemolytic reactions. In low‑resource settings, simple bedside methods and limited lab resources shape decision‑making.

Overview

Blood typing identifies the antigens on red cells (ABO) and the presence of the D antigen (Rh). The result predicts which donor blood will be compatible and which antibodies may cause hemolysis.

• Forward (cell) typing – slide agglutination: What is the patient's ABO/Rh group? – Positive agglutination indicates presence of the corresponding antigen.
• Reverse (serum) typing – tube or slide method: Does the patient have anti‑A or anti‑B antibodies? – Agglutination with known cells confirms antibody presence, confirming the forward result.
• Rh (D) testing with anti‑D reagent: Is the patient Rh‑positive? – Agglutination means D antigen present; no agglutination means Rh‑negative.
• Bedside cross‑match (if lab unavailable): Is donor blood compatible with the patient? – No hemolysis after mixing patient serum with donor cells suggests compatibility.

• ABO antigens are carbohydrate structures on the red cell membrane.
• Rh factor is a protein antigen; Rh‑positive patients have D antigen, Rh‑negative do not.

Key concepts

Understanding the immunology of ABO and Rh systems helps predict transfusion reactions and manage hemolytic disease of the newborn (HDN).

• Anti‑A and anti‑B are naturally occurring IgM; they cause immediate intravascular hemolysis.
• Anti‑D is usually IgG; it can cross the placenta and cause HDN.
• The most severe incompatibility is O‑negative donor to A‑positive recipient.

Clinical relevance

In emergencies, knowing a patient’s blood type guides rapid transfusion decisions, especially where full cross‑matching is delayed.

• Point‑of‑care ABO test strip: Can I quickly confirm ABO in a remote clinic? – Positive line indicates antigen presence; if unavailable, rely on donor O‑negative blood.
• Direct antiglobulin test (DAT): Is there immune hemolysis after transfusion? – Positive DAT suggests antibody‑mediated red cell destruction.

• Mass casualty or obstetric hemorrhage: use O‑negative blood for Rh‑negative women and O‑positive for men or Rh‑positive women.
• Sickle cell disease crises: patients often have allo‑antibodies; extended phenotyping may be needed.
• HIV/TB/malaria patients: no impact on ABO, but transfusion‑transmitted infections remain a risk; screen donors carefully.

Exam pearls

Examiners test reasoning about compatibility, emergency transfusion, and interpretation of mismatched results.

• Always state the four major incompatibilities (A→B, B→A, O→A/B/AB, Rh‑negative → Rh‑positive).
• Explain why O‑negative is the universal donor and AB‑positive the universal recipient.
• Describe steps when a cross‑match is unavailable: give O‑negative, monitor for hemolysis, arrange definitive typing ASAP.

Common mistakes

Errors often arise from assuming ABO compatibility without confirming Rh status or from misreading weak reactions.

• Giving O‑positive blood to an Rh‑negative woman of child‑bearing age.
• Relying solely on forward typing; reverse typing catches weak subgroups.
• Ignoring patient‑generated allo‑antibodies in chronically transfused patients.

Questions an examiner may ask

• A 28‑year‑old pregnant woman with unknown blood type presents with postpartum hemorrhage — what blood should you give first and why? — Give O‑negative blood; it avoids ABO and Rh incompatibility while definitive typing is arranged.
• A patient with sickle cell disease has a history of multiple transfusions and now needs a unit; how do you ensure compatibility? — Perform extended phenotyping or antibody screen; if unavailable, use least antigen‑mismatched blood and monitor closely.
• You receive a cross‑match report showing ‘compatible’ but the patient develops fever and dark urine within 30 minutes — what is the most likely cause and next step? — Acute hemolytic reaction; stop transfusion, give IV fluids, and order a DAT.
• Explain why a Rh‑negative mother with an Rh‑positive fetus should receive anti‑D immunoglobulin — to prevent maternal sensitisation that could cause hemolytic disease in future pregnancies.
• In a rural clinic without a laboratory, a child with severe anemia needs transfusion; what bedside test can you use and what are its limits? — Use a point‑of‑care ABO strip; it only determines ABO, not antibodies or Rh, so give O‑negative blood and arrange formal typing later.
• A patient on antimalarial therapy develops a sudden drop in hemoglobin after transfusion; what differential diagnoses should you consider? — Acute hemolytic reaction, malaria‑related hemolysis, or drug‑induced immune hemolysis; check DAT and review medication.
• Why is reverse typing essential even after a clear forward type? — It detects unexpected antibodies and confirms the forward result, reducing risk of missed incompatibility.
• During a massive transfusion protocol, why is it important to monitor for citrate toxicity and how does it relate to blood typing? — Citrate binds calcium causing hypocalcaemia; while unrelated to typing, it is a critical safety issue during large volume transfusion.

When to seek help

• Acute hemolytic transfusion reaction – fever, chills, dark urine, hypotension, back pain.
• Severe allergic reaction – urticaria, bronchospasm, hypotension.
• Delayed hemolysis – falling hemoglobin 7‑10 days after transfusion with jaundice.

Quick questions

Why is O‑negative considered the safest emergency blood?

It lacks A, B, and D antigens, so it rarely causes ABO or Rh incompatibility reactions.

Can a patient with sickle cell disease receive O‑positive blood?

Yes if they are Rh‑positive; otherwise give O‑negative to avoid Rh sensitisation.

What does a weak positive reaction on forward typing mean?

It may indicate a subgroup (e.g., A2) or a low‑titer antibody; confirm with reverse typing.